Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed May 14, 2024 · 10-Q · 44 days after period end · 0001437749-24-016366
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Net Income | -$7.43M | -$6.60M | -$7.37M | -$949.30K |
| EPS Diluted | — | — | — | -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end
